BDKRB2 and prostate carcinoma: Yu et al. further demonstrated that the BK-BDKRB2 axis activated Akt-mTOR signaling and downstream NF-κB and activator protein 1 (AP-1), which activated VEGF in human prostate cancer cells [24].